Urinary Bladder
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
| OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17) (NCT02097121) | Allergan | 2014-05-23 |
| Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer (NCT00847015) | Memorial Sloan Kettering Cancer Center | 2009-02-01 |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma (NCT00714948) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
Track Urinary Bladder automatically
Every clearance here is in the API, with alerts when new ones post.